iSERA Lifesciences Ltd

NSE: COVIDH · BSE: 534920 · Software & Services · 28 announcements

Share price: ₹143.90
Market cap: ₹121.0 Cr
Revenue (annual): ₹1.36 Cr
Net profit (annual): ₹0.26 Cr
P/E (TTM): 466.5×Sector 23.6×
Promoter holding: 55.07%-3.56% QoQ
FII holding: 0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Nov 2026 17:56 IST BSE

Other Announcement

iSERA Lifesciences Other Announcement

iSERA Lifesciences will not comply with Regulation 23(9) for the half year ended 30 September 2026. Its capital and net worth are below exemption thresholds.

Open announcement → Read the filing ↗

4 Nov 2026 17:36 IST BSE

Financial Results

iSERA Lifesciences Q2 FY27 Results: Net Loss of ₹0.1 Cr

iSERA Lifesciences Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗

31 Oct 2026 13:32 IST BSE

Board Meeting Date

iSERA Lifesciences Board Meeting Date

iSERA Lifesciences gave notice of a board meeting on November 4, 2026 to consider standalone unaudited results for the quarter and half year ended September 30, 2026. The filing also notes the trading window closure from October 1, 2026.

Open announcement → Read the filing ↗